# US regulators to evaluate controversial peptides backed by RFK Jr

U.S. regulatory agencies are considering the approval of peptides, a class of compounds often promoted for anti-aging and performance enhancement, which have drawn controversy and support from Robert F. Kennedy Jr. The decision could signal shifts in health policy under current political influences, impacting public access and safety standards.

**Importance:** 3/5

## Sources

### World
- [Al Jazeera](https://www.aljazeera.com/news/2026/7/22/us-regulators-to-weigh-controversial-peptides-backed-by-rfk-jr?traffic_source=rss) — Wed, 22 Jul 2026 20:39:14 +0000